Breakthrough in Cancer Research Highlighted in Our Tours

Approximately 240,000 American men will be diagnosed with prostate cancer over the next 12 months. And while the majority of these men will have slow moving cancers that don’t pose much health risk, a new study found that 90 percent of those diagnosed with prostate cancer receive treatment which is often invasive and has serious health side affects. For our client IQ Solutions representing the National Institutes of Health, we booked and produced a three hour RMT with Dr. Patricia Ganz, director of the division of cancer prevention and control research at the Jonsson Comprehensive Cancer Center. Dr. Ganz told 19 interviewers that the study found that for some men, close monitoring rather than immediate treatment is the best course. You can hear the RNR on NewsInfusion.com at this url: http://newsinfusion.com/events/prostatecancer

NBN did an RMT early in December 2011 for the American Society of Clinical Oncology on the top breakthroughs in cancer treatment in 2011. Dr. Nicholas Vogelzang said there has been continuing progress in several areas of cancer treatment in the last year, they include children’s leukemia, skin cancers, lung cancer prevention, breast cancer prevention and exciting new drugs for the treatment of cancer. The three hour tour was fully booked with 18 interviews. Despite the mostly good news, Dr. Vogelzang said nearly 1.6 million new diagnoses of cancer are expected in the next year while 572,000 Americans are expected to die of cancer this year. You can hear the RNR on NewsInfusion.com: http://newsinfusion.com/events/cancerfindings2011